Q&A: 20 Pharma analysis & QC questions – Our experts respond
Posted: 3 December 2020 | Merck | No comments yet
In this Q&A, you will find responses from our experts to the 20 toughest questions the community raised about Pharma analysis & QC challenges.
We asked the community to raise any Pharma analysis & QC questions to our technical experts. In this Q&A, you will find responses to the 20 most burning questions we received around Microbial Testing, Analytical Testing, Dissolution Testing, Method Development, Data Traceability, Regulations…
If you have any other questions, or would like more details, please feel free to contact us and we will be delighted to help you further.
Related content from this organisation
- Pursuing new paths in targeted protein degradation drug development
- Efficient shutdown recovery: leveraging RMM to unlock value and ensure environmental quality
- Improved outcome for prostate cancer patients in Phase III PROpel trial
- Testing non-inferiority for accuracy of quantitative microbiological methods
- QA/QC Microbiology/RMM In-Depth Focus 2022
